Seroepidemiology of Herpes Simplex Type 2 in Pregnant Women in Belgium

Sexually Transmitted Diseases

Volumn 31, Issue 5, 2004, Pages 297-300

  Bodeus M ^a   Laffineur, K ^a   Kabamba Mukadi, B ^a   Hubinont, C ^a   Bernard, P ^a   Goubau, P ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BELGIUM; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PREGNANCY; PREVALENCE; RACE; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGY;

ADULT; ANTIBODIES, VIRAL; BELGIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 2142827077     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000124454.51844.E7     Document Type: Article

References (28)

1. Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000; 283:791-794.
2. Langenberg AGM, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex type 1 and type 2. N Engl J Med 1999; 341:1432-1438.
3. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1997; 326:1533-1539.
4. Ashley RL. Performance and use of HSV type-specific serology tests kits. Herpes 2002; 9:38-45.
5. Turner KR, Wong EH, Kent CK, Klausner JD. Serologic herpes testing in real world: Validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis 2002; 29:422-425.
6. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35:S173-S182.
7. Garcia-Corbeira P, Hogrefe W, Aguilar L, et al. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies. J Med Virol 1999; 59:502-506.
8. Leach CT, Ashley RL, Baillargeon J, Jenson HB. Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents. Clin Diagn Lab Immunol 2002; 9:1124-1125.
9. Cherpes TL, Ashley RL, Meyn LA, Hillier SL. Longitudinal reliability of Focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus type 1 and 2 in women. J Clin Microbiol 2003; 41:671-674.
10. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002; 186:S3-S28.
11. Strutt M, Bailey J, Tenant-Flowers M, Graham D, Zuckerman M. Ethnic variation in type of genital herpes simplex virus infection in a south London genitourinary medicine clinic. J Med Virol 2003; 69:108-110.
12. Howard M, Sellors JW, Jang D, et al. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003; 41:84-89.
13. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337:509-515.
14. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289:203-209.
15. Lafferty WE, Downey L, Celum C, Wald A. Herpes virus type 1 as a cause of genital herpes: Impact on surveillance and prevention. J Infect Dis 2000; 181:1454-1457.
16. Yoshikawa T, Hill JM, Stanberry LR, Bourne N, Kurawadwala JF, Krause PR. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med 1996; 184:659-664.
17. Cone RW, Swenson PD, Hobson AC, Remington M, Corey L. Herpes simplex virus detection (HerpChek) and culture. J Clin Microbiol 1993; 31:1774-1776.
18. Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. Risk of recurrence after first episodes of genital herpes: Relation to HSV type and antibody response. N Engl J Med 1981; 305:315-319.
19. Carvalho M, de Carvalho S, Pannuti CS, Sumita LM, de Souza VA. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil. Int J Infect Dis 1998-99; 3:94-98.
20. Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW. Seroprevalence of herpes simplex virus type 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 2002; 190:153-160.
21. Kim O, Kim SS, Park MS, et al. Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals. Int J STD AIDS 2003; 14:46-49.
22. Hashido M, Lee FK, Nahmias AJ, et al. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998; 120:179-186.
23. Da Rosa-Santos OL, Goncalves Da Silva A, Pereira ACJ. Herpes simplex virus type 2 in Brazil: Seroepidemiologic survey. Int J Dermatol 1996; 35:794-796.
24. Schmogoyi M, Wald A, Corey L. Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin 1998; 12:47-61.
25. Shaw M, van der Sande M, West B, et al. Prevalence of herpes simplex type 2 and syphilis serology among young adults in a rural Gambian community. Sex Transm Infect 2001; 77:358-365.
26. Gottlieb SL, Douglas JMJ, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted disease clinics. J Infect Dis 2002; 186:1381-1389.
27. Malkin JE, Morand P, Malvy D, et al. Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect 2002; 78:201-203.
28. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001; 28:424-428.